Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation – BioSpace

Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation  BioSpace

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ — Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), announced today filing of a US patent application …